Skip to main content
Fig. 2 | Clinical Epigenetics

Fig. 2

From: Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cells

Fig. 2

Pathway analysis of PACS and SARS-CoV2 interactome. a Dot plot showing the top enriched pathways in PACS resulting from the overrepresentation analysis (Panther, PACS compared to CC19). The gene count is presented as circles, increasing with elevating number of gene count. The significance level is presented as a colour scale from red to blue. Muscarinic acetylcholine receptor M 1&3 antibodies (CHRM1&3). b Levels of Muscarinic acetylcholine receptor M3 antibodies (CHRM3) of IgG and IgM class in plasma of each study group, PACS, CC19 and Con. MFI, median fluorescence index. c String-DB interactome of PACS DMGs overlapping SARS-CoV2, expanded to fill the gaps until all major modules were connected

Back to article page